ArticleslgStudy

chemistry

Remlifanserin

Remlifanserin is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Remlifanserin rather than just read about it. In short: Remlifanserin (INNTooltip International Nonproprietary Name; developmental code name ACP-204) is a selective serotonin 5-HT2A receptor inverse agonist which is under development for the treatment of Alzheimer's disease psychosis. It is taken by mouth.

Remlifanserin — main illustration
Remlifanserin — illustration

Key takeaways

  • Remlifanserin belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Remlifanserin to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Remlifanserin from memory before moving on to harder problems.

Reference excerpt

Remlifanserin (INNTooltip International Nonproprietary Name; developmental code name ACP-204) is a selective serotonin 5-HT2A receptor inverse agonist which is under development for the treatment of Alzheimer's disease psychosis. It is taken by mouth. The drug is an improved follow-up compound to the earlier drug pimavanserin (Nuplaizid; ACP-103). It is more potent and selective than pimavanserin as a serotonin 5-HT2A receptor inverse agonist. Remlifanserin shows 32- to 123-fold selectivity for antagonism and inverse agonism of the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor depending on the bioassay. For comparison, pimavanserin's selectivity was 8- to 37-fold depending on the assay. Remlifanserin shows very low affinity for the serotonin 5-HT2B receptor compared to the serotonin 5-HT2A and 5-HT2C receptors. It is expected to have less hERG inhibition and QT prolongation than pimavanserin. The drug blocks the head-twitch response induced by the serotonergic psychedelic DOI and the hyperlocomotion induced by the NMDA receptor antagonist dizocilpine (MK-801) in rodents. It has a several-fold shorter half-life than pimavanserin (17.5–19.8 hours vs. 57 hours, respectively). Remlifanserin is under development by Acadia Pharmaceuticals. As of January 2025, it is in phase 3 clinical trials. Some of its clinicaltrials.gov identifier(s) (nct number) are NCT06159673, NCT07029581, NCT06194799, NCT07095465.

See also Serotonin 5-HT2A receptor antagonist List of investigational antipsychotics List of investigational Parkinson's disease drugs

References

Illustrations

Remlifanserin illustration

Worked examples

Example 1 — a first encounter with Remlifanserin

Start with the simplest possible case. Write down what Remlifanserin claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Remlifanserin before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Remlifanserin ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Remlifanserin

In research
Remlifanserin appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Remlifanserin in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Remlifanserin is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2,4-Difluorophenyl compounds, 5-HT2A antagonists, 5-HT2C antagonists, so understanding it makes those chapters shorter.
In everyday life
Look for Remlifanserin outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Remlifanserin in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Remlifanserin means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Remlifanserin out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Remlifanserin in simple terms?

Remlifanserin (INNTooltip International Nonproprietary Name; developmental code name ACP-204) is a selective serotonin 5-HT2A receptor inverse agonist which is under development for the treatment of Alzheimer's disease psychosis. It is taken by mouth.

Why does Remlifanserin matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Remlifanserin?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Remlifanserin.

Tags

  • 2,4-Difluorophenyl compounds
  • 5-HT2A antagonists
  • 5-HT2C antagonists
  • Cyclopropyl compounds
  • Experimental drugs for Alzheimer's disease
  • HERG blockers
  • Inverse agonists
  • Piperidines
  • Ureas

Keep exploring